Literature DB >> 12841627

Release of pro-inflammatory mediators during myocardial ischemia/reperfusion in coronary artery bypass graft surgery.

Madhulika Sharma1, Nirmal Kumar Ganguly, Gaurav Chaturvedi, Shyam K S Thingnam, Siddhartha Majumdar, Rajendar Krishan Suri.   

Abstract

Inflammation has been reported to play an important role in cardiac surgery under cardiopulmonary bypass due to systemic endotoxemia. In order to develop strategies against this injury in future we studied the combined effect of a number of inflammatory mediators in myocardial ischemia/reperfusion. Coronary sinus blood samples of ten patients undergoing coronary artery bypass graft surgery (CABG) were obtained at three time intervals (1) before onset of bypass (2) 30 min after cross clamp, and (3) 10 min after removal of cross clamp. The samples were subjected to evaluate levels of nitric oxide byproducts (nitrite and nitrate and citrulline), inflammatory cytokines (interleukin-2, interferon-gamma and interleukin-6), adhesion molecules, (CD62L and CD54), ratio of cell surface markers (CD4/CD8 and TCRalphabeta/gammadelta) cell activation markers (CD69 and HLA DR) and second messengers (protein kinase C, inositol 1,4,5 triphosphate and intracellular calcium levels). Ischemia and further reperfusion resulted in significant rise in nitrite and nitrate levels (p < 0.001), interleukin-6 (p < 0.01), CD62L (p < 0.001), CD69 (p < 0.05), protein kinase C (p < 0.001) and intracellular calcium (p < 0.001). A fall in CD4/CD8 ratio was observed on reperfusion. These changes during CABG show that ischemia/reperfusion leads to a release of an array of pro-inflammatory mediators of tissue injury, which could lead to pathophysiological changes. Hence the study suggests the need of some protective therapies against these inflammatory markers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12841627     DOI: 10.1023/a:1024155925106

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Differential patterns of neutrophil adhesion molecules during cardiopulmonary bypass in humans.

Authors:  M Galiñanes; C Watson; U Trivedi; D J Chambers; C P Young; G E Venn
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

Review 4.  The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells.

Authors:  R Testi; D D'Ambrosio; R De Maria; A Santoni
Journal:  Immunol Today       Date:  1994-10

5.  Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits.

Authors:  W T McBride; M A Armstrong; A D Crockard; T J McMurray; J M Rea
Journal:  Br J Anaesth       Date:  1995-12       Impact factor: 9.166

6.  Neutrophil activation and adhesion molecule expression in a canine model of open heart surgery with cardiopulmonary bypass.

Authors:  W J Dreyer; L H Michael; E E Millman; K L Berens
Journal:  Cardiovasc Res       Date:  1995-06       Impact factor: 10.787

7.  Intra-coronary administration of L-arginine aggravates myocardial stunning through production of peroxynitrite in dogs.

Authors:  E Mori; N Haramaki; H Ikeda; T Imaizumi
Journal:  Cardiovasc Res       Date:  1998-10       Impact factor: 10.787

8.  Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization.

Authors:  H A Hennein; H Ebba; J L Rodriguez; S H Merrick; F M Keith; M H Bronstein; J M Leung; D T Mangano; L J Greenfield; J S Rankin
Journal:  J Thorac Cardiovasc Surg       Date:  1994-10       Impact factor: 5.209

9.  Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production.

Authors:  G Del Prete; M De Carli; F Almerigogna; M G Giudizi; R Biagiotti; S Romagnani
Journal:  J Immunol       Date:  1993-01-15       Impact factor: 5.422

Review 10.  Nitric oxide: mediator, murderer, and medicine.

Authors:  E Anggård
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

View more
  5 in total

1.  Micronized purified flavonoid fraction in pretreating CABG patients.

Authors:  Mustafa Sirlak; A Ruchan Akar; Sadik Eryilmaz; Elif Kuzgun Cetinkanat; Evren Ozcinar; Bulent Kaya; Atilla Halil Elhan; Umit Ozyurda
Journal:  Tex Heart Inst J       Date:  2010

2.  Fish oil improves hemodynamic stabilization and inflammation after resuscitation in a rat model of hemorrhagic shock.

Authors:  Yang Li; Xinying Wang; Ning Li; Jieshou Li
Journal:  Lipids Health Dis       Date:  2012-01-10       Impact factor: 3.876

3.  Impact of an interleukin-1 receptor antagonist and erythropoietin on experimental myocardial ischemia/reperfusion injury.

Authors:  Christina Grothusen; Angelika Hagemann; Tim Attmann; Jan Braesen; Ole Broch; Jochen Cremer; Jan Schoettler
Journal:  ScientificWorldJournal       Date:  2012-05-02

4.  Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630].

Authors:  Cornelia W Hoedemaekers; Peter Pickkers; Mihai G Netea; Marcel van Deuren; Johannes G Van der Hoeven
Journal:  Crit Care       Date:  2005-11-16       Impact factor: 9.097

5.  The effect of preoperative intravenous paracetamol administration on postoperative fever in pediatrics cardiac surgery.

Authors:  Mohammad-Hasan Abdollahi; Khalil Foruzan-Nia; Mostafa Behjati; Babak Bagheri; Mehdi Khanbabayi-Gol; Shahla Dareshiri; Alireza Pishgahi; Rafie Zarezadeh; Nazgol Lotfi-Naghsh; Ainaz Lotfi-Naghsh; Mohammad Naghavi-Behzad
Journal:  Niger Med J       Date:  2014-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.